Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	6.25T -12.1%
Revenue (ttm)	2.40T +15.1%
Net Income	53.66B -25.2%
EPS	592.41 -25.2%
Shares Out	90.57M
PE Ratio	116.47
Forward PE	n/a
Dividend	909.09 (1.32%)
Ex-Dividend Date	n/a

Volume	3,804
Average Volume	10,678
Open	69,000
Previous Close	69,000
Day's Range	67,800 - 69,000
52-Week Range	66,200 - 86,800
Beta	0.20
RSI	52.00
Earnings Date	May 8, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2025, Ha Tay Pharmaceutical JSC's revenue was 2.40 trillion, an increase of 15.13% compared to the previous year's 2.09 trillion. Earnings were 53.66 billion, a decrease of -25.24%.